Skip to main content
Signal8

Sight Sciences, Inc. (SGHT)

Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

Sight Sciences, Inc. logo

Sight Sciences, Inc.

NASDAQ:SGHTHealthcare
-2.61%$9.32
AH$9.32+0.00%vs close
Mkt Cap$513.42M
Float36.87M
O/S55.09M
Vol
$ Vol
RVOL
Inst Own37.1%
SI3.4%
Earnings
Dilution